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coronary blood flow; norepinephrine; adenosine; feedback control CORONARY BLOOD FLOW DURING exercise is closely matched to myocardial metabolism. This linkage is thought to occur largely through the release of metabolic vasodilators by cardiac myocytes, forming a negative feedback control loop that keeps tissue oxygen tension relatively constant (15) . It has recently been proposed that exercise-induced coronary vasodilation results, in part, from feedforward ␤-adrenoceptor vasodilation mediated by catecholamines (11, 33) . The hypothesis is that the increase in sympathetic activity during exercise stimulates both increased cardiac metabolism and direct coronary vasodilation.
In the dog heart, feedforward adrenoceptor vasodilation has been demonstrated during intracoronary norepinephrine infusion (33) . However, intracoronary infusion may expose arterial vascular smooth muscle to higher norepinephrine concentrations than exist during more physiological interventions such as exercise. The direct vascular effects of intracoronary norepinephrine might therefore be exaggerated relative to the metabolic effects. Duncker et al. (11) demonstrated feedforward ␤-adrenoceptor vasodilation in exercising pigs. Unlike humans and dogs, however, pigs do not exhibit ␣-adrenergic coronary vasoconstriction during exercise (11) . The goal of the present study was to determine the extent of feedforward sympathetic ␤-adrenoceptor-mediated coronary vasodilation in exercising dogs.
The rationale used in the present study is that there are three main components that control coronary flow during exercise: 1) local metabolic vasodilation, 2) ␣-adrenoceptor-mediated vasoconstriction, and 3) ␤-adrenoceptor-mediated vasodilation. During ␣-adrenoceptor blockade, coronary vasodilation consists of the local metabolic plus ␤-adrenoceptor vasodilator components, whereas combined ␣-and ␤-adrenoceptor blockade produces a relatively "pure" local metabolic coronary vasodilation. Therefore, differences between the ␣-adrenoceptor blockade and ␣ ϩ ␤-adrenoceptor blockade conditions reflect the ␤-adrenoceptor contribution. The feedforward sympathetic vasodilation hypothesis predicts that the myocardial oxygen supply-to-consumption ratio will be reduced when ␤-adrenoceptors are blocked. Compared with ␣-adrenoceptor blockade, ␣ ϩ ␤-adrenoceptor blockade should result in lower coronary venous oxygen tensions at equivalent myocardial oxygen consumptions. In addition, arterial and coronary venous plasma adenosine concentrations were measured to evaluate the role of adenosine as a local metabolic negative-feedback vasodilator before and during adrenergic receptor blockade.
METHODS AND MATERIALS
Surgical preparation. Experiments were performed on 10 adult male mongrel dogs (weight: 23-34 kg) that were taught to run on a motorized treadmill. Preanesthesia (0.05 mg/kg acepromazine and 0.06 mg/kg atropine, subcutaneous) was administered 30 min before intravenous induction of anesthesia with 5.75 mg/kg ketamine and 0.3 mg/kg diazepam. A surgical plane of anesthesia was maintained by mechanical ventilation with 0.5-3.0% isoflurane gas. Utilizing sterile technique, a splenectomy was performed through a midline abdominal incision to minimize changes in hematocrit during exercise. After this procedure, a left lateral thoracotomy was performed in the fifth intercostal space. With the use of a modified Seldinger technique, a polyurethane catheter was implanted into the descending thoracic aorta to measure aortic blood pressure and obtain arterial blood samples. A second polyurethane catheter was placed in the coronary sinus via a purse string suture in the right atrial appendage for coronary venous blood sampling. Catheter materials and dimensions have been described in detail by Tune et al. (49) . The circumflex coronary artery was dissected free, and a flow transducer (see Pressure and flow measurement) was placed around the artery. No instruments were implanted in the myocardium, and no surgical stitches were placed in the ventricles to avoid injuring tissue that might release adenosine. A chest tube was placed to evacuate the pneumothorax, and the chest was closed in layers. The catheters and the flow transducer wire were tunneled subcutaneously and exteriorized between the scapulae. Both the abdominal and thoracic incisions were infiltrated with 2.5% bupivacaine, and 0.01 mg/kg Buprenex (Reckitt and Colman) was administered intramuscularly to minimize postoperative pain. Antibiotic (20 mg/kg cefazolin) was administered twice daily for 5 days. The animals received a multivitamin, baby aspirin (81 mg), and a dietary iron supplement (324 mg) daily. A nylon jacket (Alice King Chatham, Hawthorne, CA) was placed on the animals to protect the catheters and the flow transducer wire. Catheters were flushed daily with a high-viscosity solution of 50% glucose containing penicillin G (65,000 U/ml) and heparin (1,300 U/ml). The animals were allowed at least 10 days for recovery before experiments were conducted.
Pressure and flow measurement. A coextruded polyurethane catheter was used in the aorta so that a high-fidelity Mikro-tip catheter pressure transducer (3-Fr; SPR-524, Millar Instruments, Houston, TX) could be inserted at the time of the experiment to measure aortic blood pressure (14, 20) . The pressure transducer was introduced into the aortic catheter through a hemostatic control valve (Tuohy-Borst adapter, Mallinckrodt Medical, St. Louis, MO) that allowed arterial blood samples to be withdrawn while maintaining a fluid-tight seal.
Coronary blood flow was continuously measured throughout the experimental protocol (see Experimental protocol) with an ultrasonic, perivascular flow transducer (Transonics, Ithaca, NY). The flow transducer was calibrated before and after chronic implantation. The average difference between the before-and-after implantation slopes for the flow calibrations was 6 Ϯ 1% (SE; n ϭ 7). After all experiments were completed, the animals were euthanized with pentobarbital sodium, and the circumflex perfusion territory was dyed with India ink. The weight of the dyed tissue was used to calculate coronary blood flow per gram of perfused myocardium.
Blood sampling. Arterial and coronary venous blood samples were collected simultaneously into heparinized glass syringes that were immediately sealed and placed on ice. The samples were analyzed for hydrogen ion concentration, carbon dioxide tension, and oxygen tension with an pH/blood gas analyzer (model 1306, Instrumentation Laboratories, Waltham, MA). Oxygen content was determined using the fuel-cell method (Total O 2 X, Hospex, Chestnut Hill, MA). In addition, a portion from both the arterial and coronary venous blood samples was transferred into NaF-coated vials to prevent glycolysis, and lactate concentration was determined with a YSI lactate analyzer (model 1500, Yellow Springs Instruments, Yellow Springs, OH). Myocardial oxygen consumption (l O 2 ⅐ min Ϫ1 ⅐ g Ϫ1 ) was calculated by multiplying coronary blood flow per gram of perfused tissue by the arterial-coronary venous difference in oxygen content. Percent myocardial lactate extraction was calculated as the difference in arterial and coronary venous lactate concentration divided by the arterial lactate concentration.
Arterial and coronary venous adenosine measurements were made at rest and during steady-state conditions at each exercise level (see Experimental protocol). Plasma adenosine concentration was measured by HPLC using methods previously described in detail (49) .
Estimation of cardiac interstitial adenosine concentration. Cardiac interstitial adenosine concentration was estimated using a four-region (plasma, endothelial cell, interstitial space, parenchymal cell), axially distributed mathematical model (29, 30, 46) . The model describes the effects of blood flow and adenosine transport and exchange between tissue regions, as well as cellular production and consumption, on the relationship between arterial, venous, and interstitial adenosine concentrations. This model has been previously used to estimate interstitial adenosine concentrations in vivo, and the constraints and assumptions have been described extensively (30, 46) . The model accounts for myocardial blood flow heterogeneity and the change in heterogeneity that occurs with changes in blood flow. In addition, the model is constrained with previous estimates of capillary adenosine transport and metabolism adjusted for the level of coronary blood flow. Interstitial adenosine concentration was estimated using the measured values of coronary plasma flow and arterial plasma adenosine concentration by adjusting cellular adenosine production in the model to fit the measured coronary venous plasma adenosine concentration. Interstitial adenosine concentration was calculated at rest and during steady-state exercise conditions, with and without administration of adrenoceptor antagonists.
Experimental protocol. After an overnight fast, the dogs stood in slings while baseline data were collected. Coronary blood flow, aortic pressure, and heart rate were recorded while arterial and coronary venous blood samples were collected for measurement of blood gases, oxygen content, and lactate and adenosine concentrations. While remaining in the sling, the dogs received an intravenous infusion of either vehicle, phentolamine (l mg/kg), or phentolamine plus propranolol (1 mg/kg, each ). Five minutes after completing this infusion, postdrug baseline data were collected.
Data were subsequently collected during three levels of treadmill exercise: 1) 3 mph, 5% grade; 2) 4 mph, 10% grade; and 3) 5 mph, 15% grade. Arterial and coronary venous blood samples were collected when hemodynamic variables were stable at each level. Each exercise period was ϳ2 min in duration, and the animals were allowed to rest between each exercise level while hemodynamic variables returned to baseline.
All 10 dogs were studied under all three conditions (control, ␣-adrenoceptor blockade, ␣ ϩ ␤-adrenoceptor blockade). Experiments were performed on different days and were separated by at least 2 days. Eight of the ten chronic animals in the present study were also used in another investigation (49) .
Drugs. ␣-Adrenoceptor blockade was induced with 1 mg/kg of phentolamine. Combined ␣-and ␤-adrenoceptor blockade was produced with the same dose of phentolamine combined with 1 mg/kg of propranolol, administered simultaneously. Phentolamine and propranolol were dissolved in isotonic saline. The vehicle (control) experiments in this study were also part of concurrent studies using water-insoluble drugs. The vehicle contained, in ml, 0.5 1 N NaOH, 0.5 ethanol, and 0.5 propylene glycol in 28.5 ml of 5% glucose.
Data analysis. Unless otherwise stated, results are presented as means Ϯ SE. Resting values before drug or vehicle administration are presented in Table 1 but were not included in the statistical analysis of drug and exercise effects. For each outcome variable, the control, ␣-blockade, and ␣ ϩ ␤-blockade groups were compared using a two-way ANOVA with 10 "blocks" (dogs) and 12 "treatments" (drug-exercise combinations). When treatment means differed from equality at the P Ͻ 0.05 level according to a two-way ANOVA, the Student-Newman-Keuls test was used to test all paired comparisons between means. To compare the slopes of the coronary sinus oxygen tension vs. myocardial oxygen consumption lines, the slopes were first determined individually for each dog and each drug. These slopes were then compared using two-way ANOVA and the Student-Newman-Keuls test. The average slopes were plotted, and the regression lines were centered at the mean oxygen consumption and mean venous oxygen tension of the data set being plotted. Statistical tests were performed using SigmaStat software (SPSS) for two-way ANOVA and multiple comparisons.
RESULTS
Tracings of coronary blood flow and aortic pressure from one dog under each experimental condition, during rest and at the highest level of exercise, are presented in Fig. 1 . Figure 2 shows the predrug rest, postdrug rest, and exercise results for coronary blood flow, myocardial oxygen consumption, heart rate, mean aortic pressure, lactate extraction, and coronary venous carbon dioxide tension. During resting conditions, vehicle infusion had no effect on any of these variables. Compared with control, ␣-adrenoceptor blockade decreased mean aortic pressure and increased heart rate, whereas combined ␣ ϩ ␤-adrenoceptor blockade caused only a decrease in mean aortic pressure. During exercise, combined ␣-and ␤-adrenoceptor blockade significantly reduced coronary blood flow, myocardial oxygen consumption, heart rate, and mean aortic pressure compared with control. In relation to control, ␣-adrenoceptor blockade during exercise increased myocardial oxygen consumption at the lower exercise levels but not at the highest level. Mean aortic pressure was significantly lower than control under all conditions after ␣-adrenoceptor blockade and after ␣ ϩ ␤-adrenoceptor blockade. Lactate extraction was lower during ␣-adrenoceptor blockade, both at rest and during exercise. These data and others are summarized in Table 1 .
Because adrenoceptor blockade affects myocardial oxygen consumption, responses to exercise must also be evaluated in relation to myocardial oxygen consumption. Figure 3 contains a plot of coronary sinus oxygen tension vs. myocardial oxygen consumption under the three different experimental conditions. During control conditions, exercise resulted in a moderate decrease in coronary sinus oxygen tension with increasing myocardial oxygen consumption [ Fig. 4 . During control conditions and during ␣ ϩ ␤-adrenoceptor blockade, coronary sinus plasma adenosine did not increase significantly above resting levels at any exercise level. The estimated interstitial adenosine concentration in these two series did not reach the vasoactive threshold of ϳ117 nM (46) . During ␣-adrenoceptor blockade, however, coronary venous adenosine increased substantially in 7 of 10 dogs at the two highest exercise levels. Due to the large variability, this increase was statistically significant only at the second exercise level. Interstitial adenosine paralleled the venous adenosine and reached vasoactive concentrations at the two highest exercise levels.
DISCUSSION
The present experiments are the first to combine measurements of plasma adenosine and catecholamine concentration (17) with adrenergic blockade during exercise. The major findings are 1) ␤-adrenoceptormediated feedforward coronary vasodilation is an important component of coronary vasodilation that matches coronary blood flow to myocardial oxygen consumption during exercise. 2) Interstitial adenosine concentration does not increase to compensate for the loss of ␤-adrenoceptor-mediated coronary vasodilation during exercise. 3) Exercise during systemic ␣-adrenoceptor blockade may cause myocardial ischemia as demonstrated by high coronary venous plasma adenosine concentrations in 7 of the 10 experimental animals.
Feedforward control may also be called yoked (parallel) or open-loop control. Feedforward control differs from feedback control in that an error signal is not involved. Activation of feedback control requires an error signal that is the difference between an actual reading and some set or operating point. Local metabolic control of coronary blood flow is an example of closed-loop, negative-feedback control that tends to keep myocardial oxygen tension constant (8) . A feedforward system is activated by a direct signal that may be yoked to control two variables in parallel. The ␣-adrenoceptor-mediated vasoconstriction and ␤-adrenoceptor-mediated vasodilation observed in the present study are examples of feedforward control. The sympathetic discharge to the heart during exercise results in Values are means Ϯ SE; n, no. of animals. ␣-Blockade, ␣-adrenoceptor blockade with phentolamine (1 mg/kg body wt); ␣ϩ␤-blockade, ␣ϩ␤ adrenoceptor blockade with phentolamine plus propanolol (1 mg/kg body wt each). * P Ͻ 0.05 vs. control at same exercise level; determined by 2-way ANOVA and Student-Newman-Keuls test. a parallel or yoked discharge to the pacemaker, ventricular myocardium, and coronary vessels. During exercise, the adrenergic activation of the pacemaker and myocardium results in a large increase in myocardial oxygen consumption, whereas the parallel activation of ␤-adrenoceptor coronary vasodilation increases oxygen delivery to the heart without reference to a myocardial oxygen tension error signal. There are two theoretical strategies for obtaining rapid, accurate matching of coronary blood flow to myocardial oxygen consumption: 1) a high-gain, closed-loop feedback system or 2) adding open-loop feedforward control to a closed-loop feedback system with modest gain. High-gain feedback systems tend to be unstable, with overshoots and oscillations, or have very slow response times to avoid the instability. However, a combined feedforward and feedback control system is capable of rapid and accurate control (34) . The present results demonstrate combined adrenergic feedforward and local metabolic feedback control of coronary blood flow during exercise.
Logic of the experimental design. The increase in coronary blood flow during exercise is thought to result largely from the release of local metabolic vasodilators that are secondary to the increase in myocardial oxygen consumption (15) . Superimposed on the local metabolic vasodilation are the direct vascular effects of cardiac autonomic nerves and circulating catecholamines. It has been demonstrated many times that ␣-adrenoceptor blockade decreases coronary vascular resistance during exercise (1, 18, 23, 26, 39, 43) . This was originally interpreted to mean that the direct vascular effect of catecholamines during exercise is Fig. 1 . Recordings of coronary blood flow and aortic pressure in 1 dog at rest and during level 3 exercise. Control, data obtained after vehicle infusion; ␣-blockade, data collected after ␣-adrenoceptor blockade with phentolamine (1 mg/kg); ␣ ϩ ␤-blockade, after phentolamine plus propranolol (l mg/kg, each) administration; HR, heart rate. vasoconstriction, which is normally masked by the much larger local metabolic vasodilation. Such an analysis ignores the possibility that the vasodilation ascribed to local metabolic factors also includes a direct ␤-adrenoceptor vasodilator influence of catecholamines on coronary resistance vessels.
To separate the ␤-adrenoceptor feedforward component from local metabolic vasodilation, it is first necessary to produce metabolic vasodilation free from direct vascular catecholamine effects. In the present study, this was achieved by exercise during combined ␣-and ␤-adrenoceptor blockade with phentolamine and propranolol. Metabolic vasodilation includes all vasodilator mechanisms that are present during exercise, except for catecholamines. This response is compared with the untreated exercise response (consisting of metabolic, ␣, and ␤ components) and with the response during treatment with phentolamine alone (metabolic and ␤ components). This combination of results, in the same dogs, allows estimation of the ␣-adrenoceptor vasoconstrictor component (phentolamine response Ϫ control exercise response) and the 
␤-adrenoceptor feedforward vasodilator component (phentolamine response Ϫ metabolic response).
Balance between oxygen supply and consumption. All of the responses described above must be evaluated in relation to myocardial oxygen consumption, the primary determinant of coronary blood flow. A sensitive way to elucidate vasodilator or vasoconstrictor influences on coronary blood flow is a plot of coronary sinus oxygen tension vs. myocardial oxygen consumption. Coronary sinus oxygen tension is an index of tissue oxygenation and reflects the balance between coronary oxygen delivery and myocardial oxygen consumption. On such a plot, a vasodilator influence will either shift the line upward or make the slope more positive. A vasoconstrictor influence will shift the line downward or make the slope more negative (33) . Influences on baseline flow shift the lines in a parallel manner, whereas an intervention that affects exercise vasodilation will change the slope. An added virtue of such plots is that they facilitate comparison of experimental conditions in which heart rate and arterial pressure are different. Such differences affect coronary blood flow by changing myocardial oxygen consumption, which is accounted for in these plots. Compared with control exercise, ␣-adrenoceptor blockade shifts the slope of the coronary venous oxygen tension vs. myocardial oxygen consumption plot toward higher oxygen tensions (Fig. 3) , demonstrating the existence of ␣-adrenoceptor vasoconstriction. Compared with ␣-adrenoceptor blockade, ␣ ϩ ␤-adrenoceptor blockade makes the slope of this plot significantly more negative. This demonstrates the presence of ␤-adrenoceptor vasodilation during exercise. Quantitation of these effects in terms of blood flow is a complex issue explored in the accompanying study (17) .
Comparison with previous studies. The presence of ␣-adrenoceptor vasoconstriction in the coronary circulation has been demonstrated in previous studies of exercising dogs (1, 18, 23, 26, 39, 43) . The results in Fig. 3 confirm these findings. The purpose of the current study was to isolate ␤-adrenoceptor vasodilation, for which ␣-adrenoceptor blockade experiments were an important part of the experimental design.
Previous exercise studies in dogs have noted that ␤-adrenoceptor blockade reduces coronary blood flow at a fixed exercise intensity (4, 5, 10) . This finding alone does not demonstrate ␤-adrenoceptor feedforward vasodilation because much of the flow reduction can be attributed to decreased myocardial oxygen consumption (4, 24) . Despite the lower myocardial oxygen consumption that follows ␤-adrenoceptor blockade, coronary sinus oxygen content is reduced in exercising dogs (24) and humans (12, 27) . This finding may reflect the loss of ␤-adrenoceptor feedforward vasodilation but does not permit it to be separated from unopposed ␣-adrenoceptor vasoconstriction, as discussed below. The demonstration of ␤-adrenoceptor feedforward vasodilation therefore requires a comparison intervention that increases myocardial oxygen consumption and blood flow in the absence of both ␣-adrenoceptor vasoconstriction and ␤-adrenoceptor vasodilation.
Feedforward ␤-adrenoceptor coronary vasodilation was first clearly demonstrated in closed-chest, anesthetized dogs with paired pacing tachycardia as the stimulus for relatively pure metabolic vasodilation (33) . In that study, intracoronary norepinephrine infusion was used to simulate sympathetic activation. The conclusion from that study was that norepinephrine infusion produces approximately equal amounts of ␤-adrenoceptor vasodilation and ␣-adrenoceptor vasoconstriction. However, norepinephrine infusion may expose the arterial smooth muscle to higher concentrations than exist during exercise. The present study demonstrates that feedforward sympathetic vasodilation also occurs under the more physiological condition of exercise.
Duncker et al. (11) recently demonstrated ␤-adrenoceptor feedforward vasodilation in exercising pigs. Their experiments isolated the ␣-adrenoceptor vasoconstrictor component, which, in pigs, proved to be negligible. Unlike dogs, pigs show no decline in coronary sinus oxygen tension during normal exercise. Assuming that a decline in coronary sinus oxygen tension correlates with the error signal necessary for activating feedback metabolic vasodilation, this suggests that feedforward vasodilation may be even more important in pigs than local metabolic feedback vasodilation.
␤-Adrenoceptor subtype. Feedforward ␤-adrenoceptor vasodilation would be much simpler to demonstrate if the ␤-adrenoceptors on coronary smooth muscle were of a different subtype than the cardiac myocyte ␤-adrenoceptor. Whereas at least some of the coronary vascular receptors are ␤ 2 (19, 33, 38, 48) , there is abundant evidence for coronary vascular ␤ 1 -adrenoceptors as well (33, 40, 41, 47, 48) . Given the presence of both receptor subtypes, it is clear that full pharmacological blockade of ␤-adrenoceptor vasodilation requires a nonselective antagonist, such as the propranolol used in the present study. Selective blockade of ␤ 2 -adrenoceptors reduces coronary blood flow in dogs at a fixed exercise intensity (10, 32) , but, without measurements of myocardial oxygen consumption and coronary sinus oxygen tension, it is not clear whether this is caused solely by loss of ␤ 2 -adrenoceptor vasodilation.
Location of ␣-and ␤-adrenoceptors. One of the earliest studies of isolated coronary arteries noted that norepinephrine contracts large vessels but dilates small ones (52) . This may be explained by the distribution of ␣-and ␤-adrenoceptors along the coronary arterial tree. A subsequent in vivo study found ␣-adrenoceptor vasoconstriction only in coronary arteries larger than 100 m in diameter (9) . Conversely, ␤-adrenoceptor density varies inversely with coronary vessel diameter (36, 37) . This reciprocal gradient in adrenoceptors favors sympathetic vasodilation in resistance vessels and vasoconstriction in distribution vessels. ␣-Adrenoceptor vasoconstriction and ␤-adrenoceptor vasodilation are, therefore, not truly antagonistic but appear to be spatially distributed so as to increase coronary blood flow and improve transmural flow distribution (26) .
Study limitations. A limitation of the present study is that ␣-adrenoceptor blockade with phentolamine increases cardiac and systemic norepinephrine release [concentrations are presented in the accompanying study (17) ]. These higher norepinephrine concentrations may exaggerate feedforward ␤-adrenoceptor vasodilation. A similar problem occurs if results during ␤-blockade alone are compared with control exercise results (4, 24) . In this case, elevated catecholamine release (45) would exaggerate the unopposed ␣-adrenoceptor vasoconstriction component. Thus adrenergic blockade studies can show the presence of both ␣-and ␤-adrenoceptor-mediated effects but have inherent limitations when estimating their magnitude. Therefore, the studies in the accompanying study (17) were undertaken to estimate the ␤-feedforward vasodilator contribution at normal exercise catecholamine concentrations.
Role of adenosine as a metabolic negative feedback vasodilator. In exercising dogs, the decrease in coronary sinus oxygen tension represents an error signal and implies that local metabolic feedback vasodilation is occurring. Adenosine has long been proposed as a metabolic vasodilator in the coronary circulation (6, 7, 15) . During hypoxia or ischemia, there is compelling evidence in favor of such a role for adenosine (3, 15, 31, 42, 45) . During normal exercise, the role of adenosine is far more controversial. An increase in coronary venous plasma adenosine during exercise has been reported (13) but was not confirmed in a later study (49) . Adenosine receptor antagonists do not reduce coronary blood flow during exercise (2, 49). It has been suggested that adenosine levels may increase sufficiently to overcome the competitive blockade (21), but this was not found when adenosine concentration was measured in exercising dogs (49) .
The present experiments offer an interesting test of a subhypothesis of the adenosine hypothesis. During ␣ ϩ ␤-adrenoceptor blockade, exercise produced a significantly greater than normal fall in coronary sinus oxygen tension, even though the increase in myocardial oxygen consumption was limited (Fig. 3) . The steeper than normal decrease in coronary sinus oxygen tension means that the error signal for metabolic feedback vasodilation is greater and should result in more vasodilator production. If adenosine is one of these vasodilators, then its concentration should be high after combined adrenoceptor blockade. However, there was no significant increase in coronary venous or estimated interstitial adenosine concentration during combined adrenoceptor blockade or during control conditions. This result indicates that adenosine does not compensate for the loss of sympathetic feedforward coronary vasodilation during exercise.
A possible caveat regarding this conclusion is that both phentolamine and propranolol have been found to reduce cardiac adenosine release during hypoxia or underperfusion (16, 22, 28, 50, 51) . However, both drugs appear to exert this effect by reducing myocardial oxygen consumption relative to oxygen supply (16, 51) . In the present study, phentolamine plus propranolol treatment led to lower than normal coronary sinus oxygen tension, which is an indication of increased oxygen consumption relative to supply. It is, therefore, unlikely that these effects account for the lack of increased adenosine release during combined adrenoceptor blockade.
Adenosine during ␣-adrenoceptor blockade. The high coronary venous and estimated myocardial interstitial adenosine levels observed in 7 of the 10 dogs during exercise, with ␣-adrenoceptor blockade, indicates regional myocardial ischemia. If these values were representative of the whole myocardium, coronary blood flow would be at the maximum pharmacological value of the adenosine dose-response curve of ϳ 4 ml ⅐ min Ϫ1 ⅐ g Ϫ1 (46) rather than the ϳ 2 ml⅐ min Ϫ1 ⅐ g Ϫ1 observed during exercise in the present study. The fall in myocardial lactate extraction during exercise with ␣-adrenoceptor blockade (Fig. 2 ) also suggests regional, but not global, ischemia because overall lactate extraction remained positive. Regional adenosine release with phentolamine is not responsible for the increase in coronary venous oxygen tension compared with control exercise. Adenosine attenuates the fall in local oxygen tension in the region where it is released, but this would not increase oxygen tension above control and should have only a small effect on the global tension measured in the coronary sinus. There are two possible mechanisms for subendocardial ischemia that develops during exercise with ␣-adrenoceptor blockade: arterial hypotension and augmented coronary flow oscillations. Both of these mechanisms are probably involved in the present study.
␣-Adrenoceptor blockade prevents peripheral vasoconstriction during exercise, which results in hypotension. In the present experiments, mean aortic pressure fell to 71-75 mmHg during exercise with ␣-adrenoceptor blockade. This value is above the critical value of 60 mmHg, at which adenosine is released from the myocardium in an anesthetized autoregulation experiment (45) . However, the critical value for adenosine release may be Ͼ60 mmHg when myocardial oxygen consumption is augmented by exercise. It is well recognized that the subendocardium becomes ischemic before the subepicardium (16, 25) , and it is very likely that the elevated coronary venous adenosine observed in the present study came from the subendocardium.
Huang and Feigl (26) observed that regional coronary ␣-adrenoceptor blockade during exercise decreased subendocardial flow without hypotension. This is a paradoxical effect in which coronary vasodilation, due to ␣-adrenoceptor blockade, reduces subendocardial blood flow. The postulated mechanism for this paradoxical effect is that activation of ␣-adrenoceptors on medium-sized coronary arteries stiffens the vessels and decreases vascular compliance, which results in less coronary flow oscillation during systole and diastole. When heart rate is high, the diastolic period becomes very brief, and the next systole may begin before there is adequate blood flow in the subendocardium because the initial diastolic flow is only refilling the coronary arterial tree. The problem is exacerbated when myocardial oxygen consumption is high during exercise and the need for coronary flow is great.
Measurements of flow velocity in the penetrating septal coronary artery before and during ␣-adrenoceptor blockade confirm that ␣-adrenoceptor activation lessens wasteful coronary flow oscillations (35) . Large flow oscillations with pronounced retrograde (negative) flow can even be observed in the circumflex coronary artery during ␣-adrenoceptor blockade, as shown in Fig. 1 . Thus the change in coronary vascular complex impedance produced by ␣-adrenoceptor vasoconstriction produces a paradoxical improvement in subendocardial perfusion because there is less wasted to-and-fro flow. This effect is only important in preventing subendocardial ischemia when both heart rate and coronary blood flow are high, as occurs during exercise.
Subendocardial ischemia with adenosine release was not observed during combined adrenoceptor blockade because heart rate was not very high; systolic myocardial coronary compression was not increased by an adrenergic inotropic effect; and myocardial oxygen consumption was modest. Therefore, retrograde flow oscillations were probably not important during ␣ ϩ ␤-adrenoceptor blockade.
In summary, the present experiments demonstrate the presence of ␤-adrenoceptor-mediated feedforward sympathetic coronary vasodilation in exercising dogs. Feedforward vasodilation improves the speed and accuracy of coronary blood flow regulation without the instability found in a high-gain, local metabolic feedback system. Although metabolic feedback vasodilation almost certainly increases when feedforward vasodilation is blocked, adenosine is not the mediator of this feedback vasodilation. However, during ␣-adrenoceptor blockade, strenuous exercise leads to adenosine release from the heart. This probably represents very high adenosine concentrations in localized areas of subendocardial ischemia.
